Pills scattered on $100 bills Immunology, oncology and neurology are predicted to drive the most growth in drug spending over the next five years. (Photo: Shutterstock)

Prescription drug use in the U.S. has returned to pre-pandemic levels, and cost trends for medications were flat or declining in 2021, according to a new study. However, out-of-pocket (OOP) costs to consumers continued to increase, the researchers found.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employer-Paid